Keywords: antisoma, thioplatin, works, resistant, cancer, cells, uk

Antisoma's Thioplatin works on resistant cancer cells

Article | 15 April 2002

UK biotechnology firm Antisoma has reported encouraging results frompreclinical studies of its candidate cancer drug Thioplatin at the American Association ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Cisplatin

Cisplatin Injection

Go to drug listing